SCHEDULE 13G: AWM Investment Company Discloses 6.3% Stake in RenovoRx, Inc.

AWM Investment Company, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.3% of RenovoRx, Inc.'s common stock as of March 31, 2025.

Summary

• AWM Investment Company, Inc. (AWM), a Delaware corporation, has filed a Schedule 13G indicating beneficial ownership of 2,285,000 shares of RenovoRx, Inc. common stock.
• This stake represents 6.3% of the total class of securities.
• AWM acts as the investment adviser to three funds: Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP), and Special Situations Life Sciences Fund, L.P. (SSLS).
• The shares are held across these funds, with SSFQP holding 1,300,500 shares, CAYMAN holding 362,500 shares, and SSLS holding 622,000 shares.
• AWM holds sole voting and dispositive power over these shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of RenovoRx, Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing indicates an institutional investment firm, AWM Investment Company, has taken a significant passive stake in RenovoRx, Inc. Such disclosures are common and reflect investment firms' portfolio allocations based on their strategies.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may be viewed positively, indicating confidence from a professional investor, potentially influencing market perception and liquidity.

Key Dates

Keywords

RenovoRx Inc., AWM Investment Company, Schedule 13G, beneficial ownership, common stock, investment adviser, institutional ownership, equity stake